tradingkey.logo
tradingkey.logo
Suchen

Cencora Inc

COR
Zur Watchlist hinzufügen
261.080USD
+5.550+2.17%
Handelsschluss 05/08, 16:00ETKurse um 15 Minuten verzögert
50.80BMarktkapitalisierung
19.91KGV TTM

Cencora Inc

261.080
+5.550+2.17%

mehr Informationen über Cencora Inc Unternehmen

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Cencora Inc Informationen

BörsenkürzelCOR
Name des UnternehmensCencora Inc
IPO-datumMay 28, 1996
CEOMauch (Robert P)
Anzahl der mitarbeiter51000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 28
Addresse1 West First Avenue
StadtCONSHOHOCKEN
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19428
Telefon16107277000
Websitehttps://www.cencora.com/
BörsenkürzelCOR
IPO-datumMay 28, 1996
CEOMauch (Robert P)

Führungskräfte von Cencora Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.17K
+4.58%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%
Ms. Lori J. Ryerkerk
Ms. Lori J. Ryerkerk
Independent Director
Independent Director
1.07K
+51.91%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
168.00
-469.64%
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
Mr. Francois Mandeville
Mr. Francois Mandeville
Executive Vice President - Strategy and M&A
Executive Vice President - Strategy and M&A
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.17K
+4.58%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: 4 hours ago
Aktualisiert: 4 hours ago
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.78%
Walgreens Holding Co
3.84%
T. Rowe Price Investment Management, Inc.
3.44%
T. Rowe Price Associates, Inc.
3.41%
Andere
77.93%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.78%
Walgreens Holding Co
3.84%
T. Rowe Price Investment Management, Inc.
3.44%
T. Rowe Price Associates, Inc.
3.41%
Andere
77.93%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
56.73%
Investment Advisor/Hedge Fund
28.30%
Corporation
3.84%
Research Firm
3.04%
Pension Fund
2.35%
Bank and Trust
2.21%
Hedge Fund
2.09%
Sovereign Wealth Fund
1.31%
Family Office
1.17%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
2508
188.32M
96.79%
+947.64K
2025Q4
2325
185.17M
94.90%
+31.68K
2025Q3
2360
185.31M
95.09%
+4.64M
2025Q2
2343
180.65M
95.85%
-533.00K
2025Q1
2278
180.99M
94.03%
-1.15M
2024Q4
2205
177.00M
96.12%
-3.08M
2024Q3
2114
179.91M
93.30%
+3.58M
2024Q2
2070
176.04M
91.35%
-1.09M
2024Q1
2048
176.18M
88.49%
-350.13K
2023Q4
1964
171.90M
85.06%
+6.01M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
12.84M
6.6%
+27.28K
+0.21%
Dec 31, 2025
State Street Investment Management (US)
9.31M
4.78%
+115.19K
+1.25%
Dec 31, 2025
Walgreens Holding Co
7.47M
3.84%
-2.91M
-28.01%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
6.70M
3.44%
+4.12M
+160.07%
Dec 31, 2025
T. Rowe Price Associates, Inc.
6.63M
3.41%
-725.19K
-9.87%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.46M
2.81%
+169.06K
+3.20%
Dec 31, 2025
Fidelity Management & Research Company LLC
5.12M
2.63%
+2.18M
+73.88%
Dec 31, 2025
Wellington Management Company, LLP
4.54M
2.33%
+564.87K
+14.22%
Dec 31, 2025
JP Morgan Asset Management
4.44M
2.28%
+703.18K
+18.80%
Dec 31, 2025
Boston Partners
4.20M
2.16%
-312.63K
-6.93%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
VanEck Pharmaceutical ETF
8.42%
AdvisorShares Focused Equity ETF
5.56%
First Trust Consumer Staples Alphadex Fund
3.52%
Goldman Sachs Future Health Care Equity ETF
3.48%
VanEck Retail ETF
3.31%
Hennessy Sustainable ETF
3.08%
iShares US Consumer Staples ETF
3.02%
American Century Mid Cap Growth Impact ETF
2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
2.51%
Counterpoint Quantitative Equity ETF
2.4%
Mehr Anzeigen
VanEck Pharmaceutical ETF
Anteil8.42%
AdvisorShares Focused Equity ETF
Anteil5.56%
First Trust Consumer Staples Alphadex Fund
Anteil3.52%
Goldman Sachs Future Health Care Equity ETF
Anteil3.48%
VanEck Retail ETF
Anteil3.31%
Hennessy Sustainable ETF
Anteil3.08%
iShares US Consumer Staples ETF
Anteil3.02%
American Century Mid Cap Growth Impact ETF
Anteil2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
Anteil2.51%
Counterpoint Quantitative Equity ETF
Anteil2.4%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 2.01B USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
May 06, 2026
COR.NB Interim Cash Dividend of gross USD 0.6 paid on Jun 01, 2026 going ex on May 15, 2026
May 15, 2026
Jun 01, 2026
May 15, 2026
Feb 04, 2026
COR.NB Interim Cash Dividend of gross USD 0.6 paid on Mar 02, 2026 going ex on Feb 13, 2026
Feb 13, 2026
Mar 02, 2026
Feb 13, 2026
Nov 04, 2025
COR.NB Final Cash Dividend of gross USD 0.6 paid on Dec 01, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 01, 2025
Nov 14, 2025
Aug 06, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Sep 03, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 03, 2025
Aug 15, 2025
May 07, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Jun 02, 2025 going ex on May 16, 2025
May 16, 2025
Jun 02, 2025
May 16, 2025
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Mehr Anzeigen

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI